Antimüllerian hormone as a predictor of controlled ovarian hyperstimulation outcome: comparison of two commercial immunoassay kits (Q38477175)

3 September 2017

title

Antimüllerian hormone as a predictor of controlled ovarian hyperstimulation outcome: comparison of two commercial immunoassay kits (English)

1 reference

3 September 2017

main subject

diagnostic reagent kit

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21315333

24 November 2024

Jung Ryeol Lee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21315333

24 November 2024

Seok Hyun Kim

1 reference

3 September 2017

Byung Chul Jee

1 reference

3 September 2017

Chang Suk Suh

1 reference

3 September 2017

Ki Chul Kim

1 reference

3 September 2017

Shin Yong Moon

1 reference

3 September 2017

language of work or name

English

0 references

publication date

11 February 2011

1 reference

full work available at URL

3 September 2017

https://doi.org/10.1016/j.fertnstert.2011.01.126

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21315333

https://api.elsevier.com/content/article/PII:S0015028211001609?httpAccept=text/xml

24 November 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

https://api.elsevier.com/content/article/PII:S0015028211001609?httpAccept=text/plain

24 November 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

24 November 2024

published in

Fertility and Sterility

1 reference

3 September 2017

1 reference

3 September 2017

1 reference

3 September 2017

page(s)

2602-2604

1 reference

Antimüllerian hormone serum levels: a putative marker for ovarian aging

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Analysis of serum levels of anti-Mullerian hormone, inhibin B, insulin-like growth factor-I, insulin-like growth factor binding protein-3, and follicle-stimulating hormone with respect to age and menopausal status

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Decreased anti-Müllerian hormone and altered ovarian follicular cohort in infertile patients with mild/minimal endometriosis

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Association of anti-mullerian hormone levels with obesity in late reproductive-age women

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Serum anti-Müllerian hormone expression in women with premature ovarian failure

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Measurement of serum anti-Müllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART)

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Measurement of anti-mullerian hormone by Beckman Coulter ELISA and DSL ELISA in assisted reproduction: differences between serum and follicular fluid

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Clinical uses of anti-Müllerian hormone assays: pitfalls and promises

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Relevance of anti-Mullerian hormone measurement in a routine IVF program.

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.FERTNSTERT.2011.01.126

24 November 2024

Identifiers

DOI

1 reference

3 September 2017

1 reference